Four-factor Prothrombin Complex Concentrate Use for Bleeding Management in Adult Trauma

被引：0
|
作者：
Mora, Lidia [1 ]
Maegele, Marc [2 ]
Grottke, Oliver [3 ]
Koster, Andreas [4 ,5 ]
Stein, Philipp [6 ]
Levy, Jerrold H. [7 ]
Erdoes, Gabor [8 ]
机构：
[1] Autonomous Univ Barcelona, Vall dHebron Trauma Rehabil & Burns Hosp, Dept Anaesthesiol Intens Care & Pain Clin, Barcelona, Spain
[2] Witten Herdecke Univ, Cologne Merheim Med Ctr, Dept Trauma & Orthoped Surg, Campus Cologne Merheim, Cologne, Germany
[3] Rhenish Westphalian Tech Univ, Aachen Univ Hosp, Dept Anesthesiol, Aachen, Germany
[4] Sana Heart Ctr Cottbus, Clin Anesthesiol & Interdisciplinary Intens Care M, Cottbus, Germany
[5] Ruhr Univ Bochum, Bochum, Germany
[6] Kantons Spital St Gallen, Div Anesthesiol, Hosp Linth, St Gallen, Switzerland
[7] Duke Univ, Sch Med, Dept Anesthesiol Crit Care & Surg, Durham, NC USA
[8] Univ Bern, Bern Univ Hosp, Dept Anesthesiol & Pain Med, Inselspital, Bern, Switzerland
来源：
ANESTHESIOLOGY | 2025年 / 142卷 / 02期
关键词：
K ANTAGONIST REVERSAL; INDUCED COAGULOPATHY; ORAL ANTICOAGULANTS; THROMBIN GENERATION; ANDEXANET ALPHA; OPEN-LABEL; PLASMA; TRANSFUSION; COAGULATION; SURGERY;
D O I：
10.1097/ALN.0000000000005230
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：351 / 363
页数：13
相关论文
共 50 条
  • [41] Four-factor Prothrombin Complex Concentrate for the Management of Patients Receiving Direct Oral Activated Factor X Inhibitors
    Grottke, Oliver
    Schulman, Sam
    ANESTHESIOLOGY, 2019, 131 (05) : 1153 - 1165
  • [42] LOW- VERSUS HIGH-DOSE FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE BLEEDING REVERSAL STRATEGIES
    Wilsey, H. Andrew
    Pandya, Komal
    CRITICAL CARE MEDICINE, 2020, 48
  • [43] Four-factor prothrombin complex concentrate reverses apixaban-associated bleeding in a rabbit model of acute hemorrhage
    Herzog, E.
    Kaspereit, F.
    Krege, W.
    Mueller-Cohrs, J.
    Doerr, B.
    Niebl, P.
    Dickneite, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (12) : 2220 - 2226
  • [44] Emergent reversal of oral factor Xa inhibitors with four-factor prothrombin complex concentrate
    Lipari, Louis
    Yang, Sam
    Milligan, Brian
    Blunck, Joseph
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 38 (12): : 2641 - 2645
  • [45] COLLABORATIVE PRESCRIBING OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR EMERGENT ANTICOAGULATION REVERSAL
    Tran, Kenneth K.
    Telford, Evan D.
    Hendrickson, Andrew L.
    Franck, Andrew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 2136 - 2136
  • [46] Initiation of a fixed-dose four-factor prothrombin complex concentrate protocol
    Fuh, L.
    Goldstein, J. N.
    Hayes, B. D.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (01) : 217 - 220
  • [47] Updated recommendations for warfarin reversal in the setting of four-factor prothrombin complex concentrate
    Robinson, Danielle
    Mcfadyen, James
    Merriman, Eileen
    Wee, Tan Chee
    Baker, Ross
    Tran, Huyen
    MEDICAL JOURNAL OF AUSTRALIA, 2025, 222 (01) : 49 - 51
  • [48] Initiation of a fixed-dose four-factor prothrombin complex concentrate protocol
    L. Fuh
    J. N. Goldstein
    B. D. Hayes
    Journal of Thrombosis and Thrombolysis, 2020, 50 : 217 - 220
  • [49] Reversibility of Apixaban Anticoagulation with a Four-Factor Prothrombin Complex Concentrate in Healthy Volunteers
    Nagalla, S.
    Thomson, L.
    Oppong, Y.
    Bachman, B.
    Chervoneva, I.
    Kraft, W. K.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2016, 9 (03): : 176 - 180
  • [50] In vivo reversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrate
    Barco, Stefano
    Cheung, Y. Whitney
    Coppens, Michiel
    Hutten, Barbara A.
    Meijers, Joost C. M.
    Middeldorp, Saskia
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (02) : 255 - 261
12345